Efficacy and safety of different basal and prandial insulin analogues for the treatment of type 2 diabetes: a network meta-analysis of randomized controlled trials
The DOI matches its Crossref record; 77 of the 78 references it cites were found in a registry or an index.
Abstract
Aim The aim of the present network meta-analysis is to assess the efficacy and safety across different long and short-acting analogs for the treatment of type 2 diabetes. Methods A PubMed, EMBASE, and Cochrane Central Register of Controlled Trials databases search (20th May, 2020) for all trials with a duration ≥24 weeks comparing an analogue with another or human insulin was performed. Indirect comparisons were performed by NMA choosing glargine U100 and human regular insulin, as the reference for long- and short-acting analogues, respectively. Primary endpoints were HbA1c at 24, 52, and 104 weeks. The weighted difference in means (WDM) and Mantel-Haenzel Odds Ratio [MH-OR] with 95% Confidence Intervals (CI) were calculated for categorical and continuous variables, respectively. Results Fifty trials (n = 43) and 7 for basal and prandial analogues, respectively, enrolling 25,554 and 3184 patients with type 2 and 1 diabetes, respectively, were included. At NMA, detemir was less effective than glargine U-100 at 52 weeks. A significant reduction of 24-week HbA1c (WMD [IC]: -0.10 [-0.17, -0.03]%); and risk of total (MH-OR [IC]: 0.80 [0.70, 0.91]), and nocturnal hypoglycemia (MH-OR [IC]: 0.57 [0.45, 0.73]) was observed for basal analogues versus NPH insulin. At NMA, glargine U300 and degludec were associated with a significant reduction in the risk of nocturnal hypoglycemia. No significant differences across different short-acting insulin were observed. Conclusions This paper supp…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A modest but signi fi cant reduction in HbA1c and the risk of total and nocturnal hypoglycemia has been observed for basal insulin analogs versus NPH insulin (210).”
In the citing paper
“Longer-acting basal analogs (U-300 glargine or degludec) convey a lower nocturnal hypoglycemia risk than U-100 glargine (167,168).”
From 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2025 (2025) · cites this paper as [167]
Citations
Cites
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000100 · Cited by 28,164
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gotzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · BMJ · doi:10.1136/bmj.b2700 · Cited by 17,648
Operating characteristics of a rank correlation test for publication bias
Begg, C. B., & Mazumdar, M. (1994) · Biometrics · doi:10.2307/2533446 · Cited by 16,955
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-4-200908180-00136 · Cited by 10,349
Riddle (2003) · doi:10.2337/diacare.26.11.3080 · Cited by 1,479
Davies, M. J., D’Alessio, D. A., Fradkin, J., Kernan, W. N., Mathieu, C., Mingrone, G., Rossing, P., Tsapas, A., Wexler, D. J., & Buse, J. B. (2018) · Diabetologia · doi:10.1007/s00125-018-4729-5 · Cited by 1,455
A new improved graphical and quantitative method for detecting bias in meta-analysis
Furuya-Kanamori, L., Barendregt, J. J., & Doi, S. A. R. (2018) · International Journal of Evidence-Based Healthcare · doi:10.1097/xeb.0000000000000141 · Cited by 1,160
GRADE guidelines: 12. Preparing Summary of Findings tables—binary outcomes
Guyatt, G. H., Oxman, A. D., Santesso, N., Helfand, M., Vist, G., Kunz, R., Brozek, J., Norris, S., Meerpohl, J., Djulbegovic, B., et al. (2013) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2012.01.012 · Cited by 836
Advances in the GRADE approach to rate the certainty in estimates from a network meta-analysis
Brignardello-Petersen, R., Bonner, A., Alexander, P. E., Siemieniuk, R. A., Furukawa, T. A., Rochwerg, B., Hazlewood, G. S., Alhazzani, W., Mustafa, R. A., Murad, M. H., et al. (2018) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2017.10.005 · Cited by 753
Yki-Järvinen, H., Dressler, A., Ziemen, M., & HOE 901/300s Study Group (2000) · Diabetes Care · doi:10.2337/diacare.23.8.1130 · Cited by 579
Buse, J. B., Wexler, D. J., Tsapas, A., Rossing, P., Mingrone, G., Mathieu, C., D’Alessio, D. A., & Davies, M. J. (2020) · Diabetologia · doi:10.1007/s00125-019-05039-w · Cited by 487
Basal Insulin Therapy in Type 2 Diabetes
Rosenstock, J., Schwartz, S. L., Clark, C. M., Park, G. D., Donley, D. W., & Edwards, M. B. (2001) · Diabetes Care · doi:10.2337/diacare.24.4.631 · Cited by 478
Rosenstock, J., Davies, M., Home, P. D., Larsen, J., Koenen, C., & Schernthaner, G. (2008) · Diabetologia · doi:10.1007/s00125-007-0911-x · Cited by 447
Insulin glargine or NPH combined with metformin in type 2 diabetes: The LANMET study
Yki-Järvinen, H., Kauppinen-Mäkelin, R., Tiikkainen, M., Vähätalo, M., Virtamo, H., Nikkilä, K., Tulokas, T., Hulme, S., Hardy, K., McNulty, S., et al. (2006) · Diabetologia · doi:10.1007/s00125-005-0132-0 · Cited by 434
Reduced Hypoglycemia Risk With Insulin Glargine
Rosenstock, J., Dailey, G., Massi-Benedetti, M., Fritsche, A., Lin, Z., & Salzman, A. (2005) · Diabetes Care · doi:10.2337/diacare.28.4.950 · Cited by 371
Horvath, K., Jeitler, K., Berghold, A., Ebrahim, S. H., Gratzer, T. W., Plank, J., Kaiser, T., Pieber, T. R., & Siebenhofer, A. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005613.pub3 · Cited by 366
Riddle, M. C., Bolli, G. B., Ziemen, M., Muehlen-Bartmer, I., Bizet, F., & Home, P. D. (2014) · Diabetes Care · doi:10.2337/dc14-0991 · Cited by 354
Fritsche, A., Schweitzer, M. A., Hring, H.-U., & and the 4001 Study Group* (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-12-200306170-00006 · Cited by 331
Garber, A. J., King, A. B., Prato, S. D., Sreenan, S., Balci, M. K., Muñoz-Torres, M., Rosenstock, J., Endahl, L. A., Francisco, A. M. O., & Hollander, P. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60205-0 · Cited by 325
Bolli, G. B., Riddle, M. C., Bergenstal, R. M., Ziemen, M., Sestakauskas, K., Goyeau, H., Home, P. D., & on behalf of the EDITION 3 study investigators (2015) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12438 · Cited by 301
Haak, T., Tiengo, A., Draeger, E., Suntum, M., & Waldhäusl, W. (2005) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2004.00373.x · Cited by 277
Yki-Järvinen, H., Bergenstal, R., Ziemen, M., Wardecki, M., Muehlen-Bartmer, I., Boelle, E., & Riddle, M. C. (2014) · Diabetes Care · doi:10.2337/dc14-0990 · Cited by 274
Efficacy and safety of insulin analogues for the management of diabetes mellitus: a meta-analysis
Singh, S. R., Ahmad, F., Lal, A., Yu, C., Bai, Z., & Bennett, H. (2009) · Canadian Medical Association Journal · doi:10.1503/cmaj.081041 · Cited by 243
Long-acting insulin analogues versus NPH human insulin in type 2 diabetes
Monami, M., Marchionni, N., & Mannucci, E. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.04.007 · Cited by 211
Self-citationGRADE approach to rate the certainty from a network meta-analysis: addressing incoherence
Brignardello-Petersen, R., Mustafa, R. A., Siemieniuk, R. A. C., Murad, M. H., Agoritsas, T., Izcovich, A., Schünemann, H. J., & Guyatt, G. H. (2019) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2018.11.025 · Cited by 202
Rosenstock, J., Cheng, A., Ritzel, R., Bosnyak, Z., Devisme, C., Cali, A. M. G., Sieber, J., Stella, P., Wang, X., Frías, J. P., et al. (2018) · Diabetes Care · doi:10.2337/dc18-0559 · Cited by 196
Anderson, J. H. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.157.11.1249 · Cited by 193
Hollander, P., Cooper, J., Bregnhøj, J., & Pedersen, C. B. (2008) · Clinical Therapeutics · doi:10.1016/j.clinthera.2008.11.001 · Cited by 161
Swinnen, S. G., Dain, M.-P., Aronson, R., Davies, M., Gerstein, H. C., Pfeiffer, A. F., Snoek, F. J., DeVries, J. H., Hoekstra, J. B., & Holleman, F. (2010) · Diabetes Care · doi:10.2337/dc09-2294 · Cited by 159
Gough, S. C. L., Bhargava, A., Jain, R., Mersebach, H., Rasmussen, S., & Bergenstal, R. M. (2013) · Diabetes Care · doi:10.2337/dc12-2329 · Cited by 150
Liebl, A., Prager, R., Binz, K., Kaiser, M., Bergenstal, R., Gallwitz, B., & PREFER Study Group (2009) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2008.00915.x · Cited by 149
Yki‐Järvinen, H., Bergenstal, R. M., Bolli, G. B., Ziemen, M., Wardecki, M., Muehlen‐Bartmer, I., Maroccia, M., & Riddle, M. C. (2015) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12532 · Cited by 131
Scholtz, H. E., Pretorius, S. G., Wessels, D. H., & Becker, R. H. A. (2005) · Diabetologia · doi:10.1007/s00125-005-1916-y · Cited by 126
Heise, T., Nørskov, M., Nosek, L., Kaplan, K., Famulla, S., & Haahr, H. L. (2017) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12938 · Cited by 118
Therapy in Type 2 Diabetes: Insulin Glargine vs. NPH Insulin Both in Combination with Glimepiride
Eliaschewitz, F. G., Calvo, C., Valbuena, H., Ruiz, M., Aschner, P. J., Villena, J. E., Ramirez, L. A., & Jiménez, J. T. (2006) · Archives of Medical Research · doi:10.1016/j.arcmed.2005.10.015 · Cited by 115
Raskin, P., Gylvin, T., Weng, W., & Chaykin, L. (2009) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.989 · Cited by 113
Buse, J. B., Wexler, D. J., Tsapas, A., Rossing, P., Mingrone, G., Mathieu, C., D’Alessio, D. A., & Davies, M. J. (2020) · Diabetes Care · doi:10.2337/dc20-er07 · Cited by 111
Riddle, M. C., Yki‐Järvinen, H., Bolli, G. B., Ziemen, M., Muehlen‐Bartmer, I., Cissokho, S., & Home, P. D. (2015) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12472 · Cited by 110
Fulcher, G. R., Christiansen, J. S., Bantwal, G., Polaszewska-Muszynska, M., Mersebach, H., Andersen, T. H., & Niskanen, L. K. (2014) · Diabetes Care · doi:10.2337/dc13-2908 · Cited by 110
Terauchi, Y., Koyama, M., Cheng, X., Takahashi, Y., Riddle, M. C., Bolli, G. B., & Hirose, T. (2016) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12618 · Cited by 106
Rys, P., Wojciechowski, P., Rogoz-Sitek, A., Niesyczyński, G., Lis, J., Syta, A., & Malecki, M. T. (2015) · Acta Diabetologica · doi:10.1007/s00592-014-0698-4 · Cited by 101
Riddle, M. C., Rosenstock, J., Vlajnic, A., & Gao, L. (2014) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12225 · Cited by 98
Home, P. D., Fritsche, A., Schinzel, S., & Massi‐Benedetti, M. (2010) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2010.01232.x · Cited by 96
Short-acting insulin analogues vs. regular human insulin in type 2 diabetes: a meta-analysis
Mannucci, E., Monami, M., & Marchionni, N. (2009) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2008.00934.x · Cited by 96
Self-citationInsulin glargine versus NPH insulin therapy in Asian Type 2 diabetes patients
Pan, C., Sinnassamy, P., Chung, K.-D., & Kim, K. (2006) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2006.08.012 · Cited by 95
Rodbard, H. W., Cariou, B., Zinman, B., Handelsman, Y., Philis‐Tsimikas, A., Skjøth, T. V., Rana, A., Mathieu, C., & The BEGIN Once Long Trial Investigators (2013) · Diabetic Medicine · doi:10.1111/dme.12303 · Cited by 89
Bazzano, L. A., Lee, L. J., Shi, L., Reynolds, K., Jackson, J. A., & Fonseca, V. (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2008.02517.x · Cited by 80
Montañana, C. F., Herrero, C. H., & Fernández, M. R. (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2008.02483.x · Cited by 79
on behalf of the CONCLUDE Study Group, Philis-Tsimikas, A., Klonoff, D. C., Khunti, K., Bajaj, H. S., Leiter, L. A., Hansen, M. V., Troelsen, L. N., Ladelund, S., Heller, S., et al. (2020) · Diabetologia · doi:10.1007/s00125-019-05080-9 · Cited by 73
Melo, K., Bahia, L., Pasinato, B. P. R., Porfírio, G. J. M., Martimbianco, A. L. C., Riera, R., Calliari, L. E., Minicucci, W. J., Turatti, L. A. A., Pedrosa, H. C., et al. (2019) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-018-0397-3 · Cited by 67
Fonseca, V. A., Bell, D. S. H., Berger, S., Thomson, S. P., & Mecca, T. E. (2004) · The American Journal of the Medical Sciences · doi:10.1097/00000441-200411000-00007 · Cited by 63
Freemantle, N., Chou, E., Frois, C., Zhuo, D., Lehmacher, W., Vlajnic, A., Wang, H., Chung, H.-W., Zhang, Q., Wu, E., et al. (2016) · BMJ Open · doi:10.1136/bmjopen-2015-009421 · Cited by 60
Dornhorst, A., Lüddeke, H. ‐., Koenen, C., Merilainen, M. J., King, A. B., Robinson, A., Sreenan, S., & PREDICTIVE Study Group (2007) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2007.00816.x · Cited by 58
Ritzel, R. A., Harris, S. B., Baron, H. L., Florez, H. J., Roussel, R., Espinasse, M., Muehlen-Bartmer, I., Zhang, N., Bertolini, M., Brulle-Wohlhueter, C., et al. (2018) · Diabetes Care · doi:10.2337/dc18-0168 · Cited by 58
Yokoyama, H., Tada, J., Kamikawa, F., Kanno, S., Yokota, Y., & Kuramitsu, M. (2006) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2005.12.009 · Cited by 56
Franek, E., Haluzík, M., Canecki Varžić, S., Sargin, M., Macura, S., Zacho, J., & Christiansen, J. S. (2016) · Diabetic Medicine · doi:10.1111/dme.12982 · Cited by 51
Owens, D. R., Traylor, L., Mullins, P. R., & Landgraf, W. (2016) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2016.10.022 · Cited by 48
Madenidou, A.-V., Paschos, P., Karagiannis, T., Katsoula, A., Athanasiadou, E., Kitsios, K., Bekiari, E., Matthews, D. R., & Tsapas, A. (2018) · Annals of Internal Medicine · doi:10.7326/m18-0443 · Cited by 47
Nicolucci, A., Ceriello, A., Di Bartolo, P., Corcos, A., & Orsini Federici, M. (2020) · Diabetes Therapy · doi:10.1007/s13300-019-00732-w · Cited by 47
A generalized pairwise modelling framework for network meta-analysis
Doi, S. A. R., & Barendregt, J. J. (2018) · International Journal of Evidence-Based Healthcare · doi:10.1097/xeb.0000000000000140 · Cited by 42
Pan, C., Gross, J. L., Yang, W., Lv, X., Sun, L., Hansen, C. T., Xu, H., & Wagner, R. (2016) · Drugs in R&D · doi:10.1007/s40268-016-0134-z · Cited by 40
Elisha, B., Azar, M., Taleb, N., Bernard, S., Iacobellis, G., & Rabasa-Lhoret, R. (2015) · Hormone and Metabolic Research · doi:10.1055/s-0035-1554688 · Cited by 32
Betônico, C. C., Titan, S. M. O., Lira, A., Pelaes, T. S., Correa-Giannella, M. L. C., Nery, M., & Queiroz, M. (2019) · Clinical Therapeutics · doi:10.1016/j.clinthera.2019.07.011 · Cited by 32
Rapid-Acting Insulin Analogues in Basal-Bolus Regimens in Type 1 Diabetes Mellitus
Garg, S. K., Ampudia‐Blasco, F. J., & Pfohl, M. (2010) · Endocrine Practice · doi:10.4158/ep09294.ra · Cited by 29
Aso, Y., Suzuki, K., Chiba, Y., Sato, M., Fujita, N., Takada, Y., Murano, S., & Kuroda, H. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.06.007 · Cited by 29
Pala, L., Mannucci, E., Dicembrini, I., & Rotella, C. M. (2007) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2007.02.010 · Cited by 28
Self-citationBastyr, E. J., Huang, Y., Brunelle, R. L., Vignati, L., Cox, D. J., & Kotsanos, J. G. (2000) · Diabetes, Obesity and Metabolism · doi:10.1046/j.1463-1326.2000.00066.x · Cited by 27
Home, P. D., Bolli, G. B., Mathieu, C., Deerochanawong, C., Landgraf, W., Candelas, C., Pilorget, V., Dain, M., & Riddle, M. C. (2014) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12329 · Cited by 25
Hsia, S. H. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2010.11.028 · Cited by 20
Insulin glargine versus NPH insulin therapy in Asian Type 2 diabetes patients
Pan, Sinnassamy, Chung, Kd, Kim, K., & Kw (2007) · 中国生物学文摘 · Cited by 18
Efficacy and safety of degludec insulin: a meta-analysis of randomised trials
Monami, M., & Mannucci, E. (2013) · Current Medical Research and Opinion · doi:10.1185/03007995.2013.772507 · Cited by 15
Self-citationReal-world therapeutic benefits of patients on insulin glargine versus NPH insulin
Fießelmann, A., Wiesner, T., Fleischmann, H., & Bramlage, P. (2016) · Acta Diabetologica · doi:10.1007/s00592-016-0862-0 · Cited by 14
Berard, L., Cameron, B. R., Woo, V. C., & Stewart, J. A. (2015) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2014.12.008 · Cited by 8
Rodbard, H. W., Cariou, B., Zinman, B., Handelsman, Y., Wolden, M. L., Rana, A., & Mathieu, C. (2014) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12271 · Cited by 7
Lualdi, C., Silverii, G. A., Dicembrini, I., Pala, L., Monami, M., & Mannucci, E. (2018) · Journal of Endocrinological Investigation · doi:10.1007/s40618-018-0920-2 · Cited by 6
Self-citationWolnik, B., de Wiza, D., Szczepanik, T., Syta, A., & Klupa, T. (2020) · Journal of Diabetes Research · doi:10.1155/2020/8751348 · Cited by 5
Cited by
Davies, M. J., Aroda, V. R., Collins, B. S., Gabbay, R. A., Green, J., Maruthur, N. M., Rosas, S. E., Del Prato, S., Mathieu, C., Mingrone, G., et al. (2022) · Diabetes Care · doi:10.2337/dci22-0034 · Cited by 2,104
Davies, M. J., Aroda, V. R., Collins, B. S., Gabbay, R. A., Green, J., Maruthur, N. M., Rosas, S. E., Del Prato, S., Mathieu, C., Mingrone, G., et al. (2022) · Diabetologia · doi:10.1007/s00125-022-05787-2 · Cited by 1,048
9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Bajaj, M., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Echouffo-Tcheugui, J. B., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s009 · Cited by 728
9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2024
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Gaglia, J. L., Hilliard, M. E., Johnson, E. L., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s009 · Cited by 662
Samson, S. L., Vellanki, P., Blonde, L., Christofides, E. A., Galindo, R. J., Hirsch, I. B., Isaacs, S. D., Izuora, K. E., Low Wang, C. C., Twining, C. L., et al. (2023) · Endocrine Practice · doi:10.1016/j.eprac.2023.02.001 · Cited by 375
Metadata
- Authors
- Mannucci, E., Caiulo, C., Naletto, L., Madama, G., & Monami, M.
- Affiliations
- Azienda Ospedaliero-Universitaria Careggi (IT)
- University of Florence (IT)
- Corresponding author
- Monami, Matteo
- Venue
- Endocrine
- Published
- 2021-10-02
- Volume
- 74
- Issue
- 3
- Pages
- 508-517
- ISSN
- 0969-711X (ISSN-L)
- 1355-008X
- 1559-0100
- OpenAlex
- W3202105191
- Cited by
- 30
- References
- 78
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 5 · 2023: 10 · 2022: 6
- FWCI
- 0.81
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Endocrine (publishedVersion)
- PubMed (publishedVersion)
- Florence Research (University of Florence) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- type 2 diabetes, insulin analogues, basal insulin, prandial insulin, long-acting insulin, short-acting insulin, detemir, insulin degludec, NPH insulin, HbA1c, glycemic control, nocturnal hypoglycemia, insulin safety
- MeSH terms
- Network Meta-Analysis, Diabetes Mellitus, Type 2, Glycated Hemoglobin, Humans, Hypoglycemic Agents, Insulin, Randomized Controlled Trials as Topic, Insulin, Long-Acting
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.